MERAVIDA
The computed 12-month bankruptcy probability of MERAVIDA is 0.4% (very low). The 2024 annual accounts show equity of €398k and a net result of €68k. Its solvency ranks better than 23% of 1391 sector peers (fiscal year 2024). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €398k |
| Net result | €68k |
| Staff (FTE) | 1.1 |
| Better than sector | 23% |
Mixed profile: strong on profitability, weaker on solvency.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 15.2% | 43.6% | |
| Net result | €68k | €41k | |
| Equity | €398k | €163k | |
| Gross operating margin | €427k | €72k | |
| Staff costs | €50k | €106k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €373k |
| Net profit | €68k |
| Cash flow | €293k |
| Staff costs | €50k |
| Income taxes | €28k |
| Dividends | - |
| Total assets | €2.62M |
| Equity | €398k |
| Debt | €2.23M |
| of which ≤ 1y | €2.18M |
| of which > 1y | - |
| Working capital | €-1.93M |
| Employees (FTE) | 1.1 |
| 2024 | |
|---|---|
| Current ratio | 0.12 |
| Quick ratio | 0.12 |
| Working capital ratio | -73.4% |
| Solvency | 15.2% |
| Debt / equity | 5.60 |
| Long-term debt ratio | - |
| Interest coverage | 7.18 |
| Gross margin | - |
| Net margin | - |
| ROA | 2.6% |
| ROE | 17.0% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €2.62M |
| Fixed assets | 21/28 | €2.37M |
| Tangible fixed assets | 22/27 | €2.37M |
| Financial fixed assets | 28 | €888 |
| Current assets | 29/58 | €254k |
| Amounts receivable within one year | 40/41 | €155k |
| Cash & bank | 54/58 | €82k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €2.62M |
| Equity | 10/15 | €398k |
| Contributions / capital | 10/11 | €330k |
| Accumulated profits (losses) | 14 | €68k |
| Amounts payable | 17/49 | €2.23M |
| Amounts payable within one year | 42/48 | €2.18M |
| Trade debts payable within one year | 44 | €985k |
| Income statement | ||
| Gross operating margin | 9900 | €427k |
| Operating result | 9901 | €147k |
| Financial income | 75 | €13 |
| Financial charges | 65 | €52k |
| Result before taxes | 9903 | €95k |
| Income taxes | 67/77 | €28k |
| Net result for the period | 9904 | €68k |
| Result to be appropriated | 9905 | €68k |
| NACE primary | Head office activities(70100) |
| Legal form | Private limited company(610) |
| Incorporation | 18-10-2023 |
| Status | Active |
| Postal code | 2480 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 13006E0471/00F000 | Flanders | 1,612 m² | 1 · 380 m² | 7.2 m · 1 fl. |
| 13011A0028/00N000 | Flanders | 405 m² | 1 · 232 m² | 8.8 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
15-01-2024 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": null,
"notary": {
"name": "Frederik Vandenbriele",
"firm_city": null,
"firm_name": null,
"office_city": "Oostende",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-01-15",
"filing_date": "2024-01-11",
"act_kind_objet": "DIVERSEN"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2023-12-07",
"unanimous": null
},
"conversion": null,
"detected_kind": "other",
"report_waiver": {
"summary": "De aandeelhouder verzaakt aan het opstellen van het verslag van het bestuursorgaan dat de uitgifteprijs verantwoordt en de gevolgen van de verrichting voor de vermogens- en lidmaatschapsrechten van de aandeelhouders beschrijft.",
"articles": [
"5:121 \u00A72",
"5:121",
"5:130"
]
},
"restructuring": {
"parties": [
{
"kbo": "1001.356.041",
"name": "MERAVIDA",
"role": "other",
"address": "Warande 71, 2480 Dessel",
"is_foreign": false,
"legal_form": "Besloten Vennootschap",
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": null,
"legal_articles": [],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": null,
"real_estate_included": false,
"patrimony_description": null,
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "1001.356.041",
"name_full": "MERAVIDA",
"legal_form": "Besloten Vennootschap"
},
"detected_kind_raw": "material_correction",
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Frederik Vandenbriele",
"org_rep_person_name": null
},
"summary_narrative": "De buitengewone algemene vergadering van MERAVIDA heeft besloten om de verplichting tot het opstellen van het verslag van het bestuursorgaan te verzuiken, het eigen vermogen te verhogen met 230.000 euro door een inbreng in geld zonder uitgifte van nieuwe aandelen, en de bestuurders gemachtigd te geven om de genomen beslissingen uit te voeren.",
"co_filed_documents": [
"expeditie (met aangehechte bijlage)",
"herbevestiging oorspronkelijke statuten"
],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | MERAVIDA |